Banque Transatlantique’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Banque Transatlantique's AMGN Position: Q2 2026 in Review
Banque Transatlantique reduced its Amgen (AMGN) stake by 0.72% in Q2 2026, selling an estimated $9.24K and leaving 3,698 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #144.
Banque Transatlantique first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.31M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Banque Transatlantique held 3,698 shares of Amgen worth $1.31M as of Q2 2026.
- Banque Transatlantique sold 27 Amgen shares in Q2 2026, an estimated $9.24K.
- Amgen made up 0.03% of Banque Transatlantique's portfolio in Q2 2026, its #144 holding.
- Banque Transatlantique first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- Banque Transatlantique's Amgen position peaked at $1.31M in Q1 2026.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.